<DOC>
	<DOC>NCT01609400</DOC>
	<brief_summary>The study evaluates degradation of NASHA in breast 4 and 6 years post treatment, long term safety and evaluation if a satisfactory breast cancer screening can be performed in subjects treated with NASHA-gel in breast. An independent evaluation of the aesthetic changes is also performed.</brief_summary>
	<brief_title>An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast</brief_title>
	<detailed_description />
	<criteria>subject treated with NASHAgel in the breasts in study 31GB0607 signed informed consent no exclusion criteria in this study</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>